Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryoport Inc CYRX

Consumer Cyclical Technology Scientific & Technical Instruments Industrials
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its... see more

Recent & Breaking News (NDAQ:CYRX)

Cryoport Signs Strategic Agreement to Support Tissue Solutions Transportation of Human Cells and Cryopreserved Cell Lines

PR Newswire June 8, 2016

Cryoport Reminds All Interested Parties That Today is the Final Day to Become a Rights Offering Record Date Holder

PR Newswire May 25, 2016

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

PR Newswire May 23, 2016

Cryoport Announces Share Pricing Period and Record Date for Shareholder and Warrant Holder Rights Offering

PR Newswire May 16, 2016

Cryoport Agreement with Cryo Store BV Expands European Presence for its Best-in-Class Cryogenic Logistics Solutions

PR Newswire May 6, 2016

Cryoport Files S-1 Registration Statement for Rights Offering

PR Newswire April 28, 2016

Cryoport Signs Strategic Partnership Deal With Worthington Industries

PR Newswire April 13, 2016

Cryoport Announces Global Temperature Controlled Logistics Consulting Services

PR Newswire April 11, 2016

Cryoport Chosen to Provide Cold Chain Logistics Support to ProteoGenex

PR Newswire April 4, 2016

UPS Adds Cryogenic Shipping to Its Temperature-Sensitive Portfolio In Europe

PR Newswire March 15, 2016

Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics

PR Newswire March 3, 2016

Cryoport Supports Perseus PCI in Melanoma and Ovarian Cancer Clinical Trials

Press Releases February 16, 2016

Cryoport Reports 50% Revenue Growth for the Third Quarter of Fiscal Year 2016

PR Newswire February 8, 2016

Cryoport to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

PR Newswire February 4, 2016

Cryoport to Report Third Quarter Fiscal 2016 Financial Results on February 8th

PR Newswire February 2, 2016

Cryoport Introduces Its Advanced Cryogenic Logistics Solutions for IVF to the Cambodia and Czech Republic Markets

PR Newswire January 26, 2016

Cryoport Is Selected By Morphotek to Manage Cold Chain Logistics

Business Wire January 13, 2016

Cryoport Announces Opening of New US Headquarters

PR Newswire December 8, 2015

Cryoport Expands its Support of the Contract Research and Testing Arena

PR Newswire December 1, 2015

Cryoport Revenues Climb 74% for the Second Quarter of Fiscal Year 2016

PR Newswire November 16, 2015